{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T23:58:24Z","timestamp":1790812704649,"version":"4.1.0"},"reference-count":40,"publisher":"Public Library of Science (PLoS)","issue":"12","license":[{"start":{"date-parts":[[2014,12,1]],"date-time":"2014-12-01T00:00:00Z","timestamp":1417392000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0113931","type":"journal-article","created":{"date-parts":[[2014,12,1]],"date-time":"2014-12-01T21:04:20Z","timestamp":1417467860000},"page":"e113931","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":30,"title":["Distinct Behaviour of Sorafenib in Experimental Cachexia-Inducing Tumours: The Role of STAT3"],"prefix":"10.1371","volume":"9","author":[{"given":"M\u00edriam","family":"Toledo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabio","family":"Penna","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S\u00edlvia","family":"Busquets","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francisco J.","family":"L\u00f3pez-Soriano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Josep M.","family":"Argil\u00e9s","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2014,12,1]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.ejca.2005.07.026","article-title":"Prevention and treatment of cancer cachexia: new insights into an old problem","volume":"42","author":"M Muscaritoli","year":"2006","journal-title":"Eur J Cancer"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"225","DOI":"10.3322\/canjclin.57.4.225","article-title":"(n.d.) The lethal phenotype of cancer: the molecular basis of death due to malignancy","volume":"57","author":"RD Loberg","journal-title":"CA Cancer J Clin"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"996","DOI":"10.1038\/sj.bjc.6601620","article-title":"Reduced total energy expenditure and physical activity in cachectic patients with pancreatic cancer can be modulated by an energy and protein dense oral supplement enriched with n-3 fatty acids","volume":"90","author":"AWG Moses","year":"2004","journal-title":"Br J Cancer"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1016\/S0149-2918(05)80001-3","article-title":"Prognostic effect of weight loss prior to chemotherapy in cancer patients. Eastern Cooperative Oncology Group","volume":"69","author":"WD Dewys","year":"1980","journal-title":"Am J Med"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/j.clnu.2009.12.004","article-title":"Consensus definition of sarcopenia, cachexia and pre-cachexia: joint document elaborated by Special Interest Groups (SIG) \u201ccachexia-anorexia in chronic wasting diseases\u201d and \u201cnutrition in geriatrics\u201d","volume":"Vol. 29","author":"M Muscaritoli","year":"2010","journal-title":"Clinical nutrition (Edinburgh, Scotland)"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1016\/j.clnu.2008.06.013","article-title":"Cachexia: a new definition","volume":"27","author":"WJ Evans","year":"2008","journal-title":"Clin Nutr"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1002\/(SICI)1098-1128(199709)17:5<477::AID-MED3>3.0.CO;2-R","article-title":"The metabolic basis of cancer cachexia","volume":"17","author":"JM Argil\u00e9s","year":"1997","journal-title":"Med Res Rev"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/S0889-8588(18)30460-X","article-title":"Nutritional support and cancer cachexia. Evolving concepts of mechanisms and adjunctive therapies","volume":"5","author":"EH Ng","year":"1991","journal-title":"Hematol Oncol Clin North Am"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1093\/ajcn\/84.3.475","article-title":"The underappreciated role of muscle in health and disease","volume":"84","author":"RR Wolfe","year":"2006","journal-title":"Am J Clin Nutr"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1097\/00000658-200101000-00003","article-title":"Muscle cachexia: current concepts of intracellular mechanisms and molecular regulation","volume":"233","author":"PO Hasselgren","year":"2001","journal-title":"Ann Surg"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/S1479-666X(06)80004-1","article-title":"The molecular mechanisms of skeletal muscle wasting: implications for therapy","volume":"4","author":"RJE Skipworth","year":"2006","journal-title":"Surgeon"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"4294","DOI":"10.1111\/febs.12253","article-title":"Mechanisms regulating skeletal muscle growth and atrophy","volume":"280","author":"S Schiaffino","year":"2013","journal-title":"FEBS J"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1097\/SPC.0b013e3283311d09","article-title":"The role of cytokines in cancer cachexia","volume":"3","author":"JM Argil\u00e9s","year":"2009","journal-title":"Curr Opin Support Palliat Care"},{"key":"ref14","first-page":"1","article-title":"Mechanisms and treatment of cancer cachexia","author":"JM Argil\u00e9s","year":"2012","journal-title":"Nutr Metab Cardiovasc Dis"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1016\/j.ygyno.2011.12.435","article-title":"A randomized phase III clinical trial of a combined treatment for cachexia in patients with gynecological cancers: evaluating the impact on metabolic and inflammatory profiles and quality of life","volume":"124","author":"A Macci\u00f2","year":"2012","journal-title":"Gynecol Oncol"},{"key":"ref16","article-title":"Phase I\/II trial of formoterol fumarate combined with megestrol acetate in cachectic patients with advanced malignancy","author":"CA Greig","year":"2014","journal-title":"Support Care Cancer"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1007\/s13539-011-0049-z","article-title":"Myostatin blockage using actRIIB antagonism in mice bearing the Lewis lung carcinoma results in the improvement of muscle wasting and physical performance","volume":"3","author":"S Busquets","year":"2012","journal-title":"J Cachexia Sarcopenia Muscle"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1016\/j.cell.2010.07.011","article-title":"Reversal of cancer cachexia and muscle wasting by ActRIIB antagonism leads to prolonged survival","volume":"142","author":"X Zhou","year":"2010","journal-title":"Cell"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1242\/dmm.008839","article-title":"Importance of functional and metabolic impairments in the characterization of the C-26 murine model of cancer cachexia","volume":"5","author":"KT Murphy","year":"2012","journal-title":"Dis Model Mech"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"7099","DOI":"10.1158\/0008-5472.CAN-04-1443","article-title":"BAY 43-9006 exhibits broad spectrum oral antitumor activity and targets the RAF\/MEK\/ERK pathway and receptor tyrosine kinases involved in tumor progression and angiogenesis","volume":"64","author":"SM Wilhelm","year":"2004","journal-title":"Cancer Res"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1056\/NEJMoa0708857","article-title":"Sorafenib in advanced hepatocellular carcinoma","volume":"359","author":"JM Llovet","year":"2008","journal-title":"N Engl J Med"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"7271","DOI":"10.1158\/1078-0432.CCR-06-1249","article-title":"Sorafenib for the treatment of advanced renal cell carcinoma","volume":"12","author":"RC Kane","year":"2006","journal-title":"Clin Cancer Res"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1200\/JCO.2009.24.9730","article-title":"Association of skeletal muscle wasting with treatment with sorafenib in patients with advanced renal cell carcinoma: results from a placebo-controlled study","volume":"28","author":"S Antoun","year":"2010","journal-title":"J Clin Oncol"},{"key":"ref24","first-page":"408","article-title":"Sorafenib downregulates ERK\/Akt and STAT3 survival pathways and induces apoptosis in a human neuroblastoma cell line","volume":"3","author":"H Chai","year":"2010","journal-title":"Int J Clin Exp Pathol"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"11851","DOI":"10.1158\/0008-5472.CAN-06-1377","article-title":"Sorafenib blocks the RAF\/MEK\/ERK pathway, inhibits tumor angiogenesis, and induces tumor cell apoptosis in hepatocellular carcinoma model PLC\/PRF\/5","volume":"66","author":"L Liu","year":"2006","journal-title":"Cancer Res"},{"key":"ref26","doi-asserted-by":"crossref","unstructured":"Yang F, Jove V, Buettner R, Xin H, Wu J, <etal>et al<\/etal>. (2012) Sorafenib inhibits endogenous and IL-6\/S1P induced JAK2-STAT3 signaling in human neuroblastoma, associated with growth suppression and apoptosis: 534\u2013541.","DOI":"10.4161\/cbt.19603"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1158\/1535-7163.MCT-09-0947","article-title":"Sorafenib induces growth arrest and apoptosis of human glioblastoma cells through the dephosphorylation of signal transducers and activators of transcription 3","volume":"9","author":"F Yang","year":"2010","journal-title":"Mol Cancer Ther"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"1560","DOI":"10.1038\/bjc.1996.294","article-title":"The relationship between weight loss and interleukin 6 in non-small-cell lung cancer","volume":"73","author":"HR Scott","year":"1996","journal-title":"Br J Cancer"},{"key":"ref29","first-page":"1091","article-title":"Pro-inflammatory cytokine release by peripheral blood mononuclear cells from patients with advanced pancreatic cancer: relationship to acute phase response and survival","volume":"21","author":"AGW Moses","year":"2009","journal-title":"Oncol Rep"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1016\/0014-2964(78)90203-7","article-title":"Growth and metastasis of the Lewis lung carcinoma in mice defibrinated with batroxobin","volume":"14","author":"MB Donati","year":"1978","journal-title":"Eur J Cancer"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"2189","DOI":"10.1002\/cncr.21013","article-title":"Body composition and time course changes in regional distribution of fat and lean tissue in unselected cancer patients on palliative care\u2013correlations with food intake, metabolism, exercise capacity, and hormones","volume":"103","author":"M Fouladiun","year":"2005","journal-title":"Cancer"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1126\/science.1198973","article-title":"Adipose triglyceride lipase contributes to cancer-associated cachexia","volume":"333","author":"SK Das","year":"2011","journal-title":"Science"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"E171","DOI":"10.1152\/ajpendo.00065.2013","article-title":"Exercise restores decreased physical activity levels and increases markers of autophagy and oxidative capacity in myostatin\/activin-blocked mdx mice","volume":"305","author":"JJ Hulmi","year":"2013","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"e13604","DOI":"10.1371\/journal.pone.0013604","article-title":"Muscle wasting and impaired myogenesis in tumor bearing mice are prevented by ERK inhibition","volume":"5","author":"F Penna","year":"2010","journal-title":"PLoS One"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"4821","DOI":"10.1172\/JCI68523","article-title":"NF-\u03baB-mediated Pax7 dysregulation in the muscle microenvironment promotes cancer cachexia","volume":"123","author":"WA He","year":"2013","journal-title":"J Clin Invest"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"e22538","DOI":"10.1371\/journal.pone.0022538","article-title":"STAT3 activation in skeletal muscle links muscle wasting and the acute phase response in cancer cachexia","volume":"6","author":"A Bonetto","year":"2011","journal-title":"PLoS One"},{"key":"ref37","doi-asserted-by":"crossref","first-page":"1706","DOI":"10.1002\/ijc.25146","article-title":"Muscle atrophy in experimental cancer cachexia: is the IGF-1 signaling pathway involved?","volume":"127","author":"F Penna","year":"2010","journal-title":"Int J Cancer"},{"key":"ref38","doi-asserted-by":"crossref","first-page":"1182","DOI":"10.1038\/nm.3656","article-title":"STAT3 signaling controls satellite cell expansion and skeletal muscle repair","volume":"20","author":"MT Tierney","year":"2014","journal-title":"Nat Med"},{"key":"ref39","doi-asserted-by":"crossref","first-page":"1174","DOI":"10.1038\/nm.3655","article-title":"Inhibition of JAK-STAT signaling stimulates adult satellite cell function","volume":"20","author":"FD Price","year":"2014","journal-title":"Nat Med"},{"key":"ref40","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1097\/MCO.0b013e3283455d45","article-title":"Two faces of drug therapy in cancer: drug-related lean tissue loss and its adverse consequences to survival and toxicity","volume":"14","author":"CMM Prado","year":"2011","journal-title":"Curr Opin Clin Nutr Metab Care"}],"container-title":["PLoS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0113931","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,9]],"date-time":"2020-05-09T12:47:07Z","timestamp":1589028427000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0113931"}},"subtitle":[],"editor":[{"given":"Mike","family":"Chen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2014,12,1]]},"references-count":40,"journal-issue":{"issue":"12","published-online":{"date-parts":[[2014,12,1]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0113931","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,12,1]]}}}